SSRM vs. AQST
SSRM (SSR Mining Inc.) and AQST (Aquestive Therapeutics, Inc.) are both stocks. SSRM operates in Gold (Basic Materials), while AQST operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, SSRM returned 9.84%/yr vs -0.29%/yr for AQST. At a 0.10 correlation, their price movements are largely independent.
Performance
SSRM vs. AQST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SSRM achieves a 24.22% return, which is significantly higher than AQST's -35.45% return.
SSRM
- 1D
- 3.46%
- 1M
- -21.64%
- YTD
- 24.22%
- 6M
- 22.60%
- 1Y
- 119.07%
- 3Y*
- 25.15%
- 5Y*
- 9.84%
- 10Y*
- 9.58%
AQST
- 1D
- -0.95%
- 1M
- 0.97%
- YTD
- -35.45%
- 6M
- -32.85%
- 1Y
- 25.98%
- 3Y*
- 22.65%
- 5Y*
- -0.29%
- 10Y*
- —
SSRM vs. AQST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
SSRM SSR Mining Inc. | 24.22% | 214.94% | -35.32% | -29.94% | -10.02% | -10.90% | 4.41% | 59.31% | 16.14% |
AQST Aquestive Therapeutics, Inc. | -35.45% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -58.14% |
Correlation
The correlation between SSRM and AQST is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018 | 0.10 |
Fundamentals
SSRM:
$5.93B
AQST:
$511.28M
SSRM:
$3.27
AQST:
-$0.61
SSRM:
3.11
AQST:
9.42
SSRM:
$1.90B
AQST:
$50.27M
SSRM:
$643.76M
AQST:
$20.92M
SSRM:
$835.27M
AQST:
-$53.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SSRM vs. AQST — Risk / Return Rank
SSRM
AQST
SSRM vs. AQST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SSR Mining Inc. (SSRM) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SSRM | AQST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.49 | ||
| Sortino ratioReturn per unit of downside risk | +1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.16 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 3.83 | 0.43 | +3.40 |
| Martin ratioReturn relative to average drawdown | 9.89 | 0.81 | +9.07 |
Loading charts...
Drawdowns
SSRM vs. AQST - Drawdown Comparison
The maximum SSRM drawdown since its inception was -91.68%, smaller than the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for SSRM and AQST.
Loading charts...
Drawdown Indicators
| SSRM | AQST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.68% | -96.68% | +5.00% |
Max Drawdown (1Y)Largest decline over 1 year | -31.28% | -60.61% | +29.33% |
Max Drawdown (3Y)Largest decline over 3 years | -73.41% | -63.55% | -9.86% |
Max Drawdown (5Y)Largest decline over 5 years | -83.16% | -90.11% | +6.95% |
Max Drawdown (10Y)Largest decline over 10 years | -83.16% | — | — |
Current DrawdownCurrent decline from peak | -37.45% | -78.01% | +40.56% |
Average DrawdownAverage peak-to-trough decline | -57.15% | -76.92% | +19.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.09% | 32.01% | -19.92% |
Volatility
SSRM vs. AQST - Volatility Comparison
The current volatility for SSR Mining Inc. (SSRM) is 19.31%, while Aquestive Therapeutics, Inc. (AQST) has a volatility of 21.51%. This indicates that SSRM experiences smaller price fluctuations and is considered to be less risky than AQST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SSRM | AQST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.31% | 21.51% | -2.20% |
Volatility (6M)Calculated over the trailing 6-month period | 54.27% | 68.41% | -14.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.63% | 85.07% | -18.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.93% | 82.62% | -26.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.96% | 87.69% | -34.73% |
Dividends
SSRM vs. AQST - Dividend Comparison
Neither SSRM nor AQST has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSRM SSR Mining Inc. | 0.00% | 0.00% | 0.00% | 2.60% | 1.79% | 1.13% |
Financials
SSRM vs. AQST - Financials Comparison
This section allows you to compare key financial metrics between SSR Mining Inc. and Aquestive Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SSRM vs. AQST - Profitability Comparison
SSRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported a gross profit of 0.00 and revenue of 581.78M. Therefore, the gross margin over that period was 0.0%.
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
SSRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported an operating income of 300.38M and revenue of 581.78M, resulting in an operating margin of 51.6%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
SSRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported a net income of 369.74M and revenue of 581.78M, resulting in a net margin of 63.6%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
Frequently Asked Questions
SSRM and AQST have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (21.51%) compared to SSRM (19.31%). In terms of maximum drawdown, SSRM dropped -91.68% vs AQST's -96.68%.
SSRM currently has the higher Sharpe Ratio (1.80 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SSRM and AQST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer